1. Eckert, Mark A, Coscia, Fabian, Chryplewicz, Agnieszka, Mann, Matthias, Lengyel, Ernst. 2019. Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts. In Nature, 569, 723-728. doi:10.1038/s41586-019-1173-8. https://pubmed.ncbi.nlm.nih.gov/31043742/
2. Song, Qing, Chen, Yingli, Wang, Jun, Zhou, Zhangxiang, Song, Zhenyuan. 2020. ER stress-induced upregulation of NNMT contributes to alcohol-related fatty liver development. In Journal of hepatology, 73, 783-793. doi:10.1016/j.jhep.2020.04.038. https://pubmed.ncbi.nlm.nih.gov/32389809/
3. Kraus, Daniel, Yang, Qin, Kong, Dong, Puigserver, Pere, Kahn, Barbara B. . Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. In Nature, 508, 258-62. doi:10.1038/nature13198. https://pubmed.ncbi.nlm.nih.gov/24717514/
4. Yang, Meihua, Wang, Bo, Hou, Weibin, Lin, Tianxin, Huang, Jian. 2024. NAD+ metabolism enzyme NNMT in cancer-associated fibroblasts drives tumor progression and resistance to immunotherapy by modulating macrophages in urothelial bladder cancer. In Journal for immunotherapy of cancer, 12, . doi:10.1136/jitc-2024-009281. https://pubmed.ncbi.nlm.nih.gov/39067875/
5. Sun, Wei-Dong, Zhu, Xiao-Juan, Li, Jing-Jing, Li, Wen-Song, Li, Jiang-Hua. 2024. Nicotinamide N-methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome. In Frontiers in pharmacology, 15, 1410479. doi:10.3389/fphar.2024.1410479. https://pubmed.ncbi.nlm.nih.gov/38919254/